EDGAR Filing Documents for 0001193125-12-212281

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-12-212281

Filing Date

2012-05-04

Accepted

2012-05-04 17:08:48

Documents

Period of Report

2012-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d317956d10q.htm	10-Q	672397
2	TRANSITION AND RETIREMENT AGREEMENT BETWEEN THE COMPANY AND TED LOVE, M.D.	d317956dex1030ii.htm	EX-10.30(II)	172237
3	CERTIFICATION OF CEO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A)	d317956dex311.htm	EX-31.1	8841
4	CERTIFICATION OF CFO AS REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A)	d317956dex312.htm	EX-31.2	8899
5	CERTIFICATIONS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B)	d317956dex321.htm	EX-32.1	6178
	Complete submission text file	0001193125-12-212281.txt		4756805

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	onxx-20120331.xml	EX-101.INS	694052
7	XBRL TAXONOMY EXTENSION SCHEMA	onxx-20120331.xsd	EX-101.SCH	37777
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	onxx-20120331_cal.xml	EX-101.CAL	51118
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	onxx-20120331_def.xml	EX-101.DEF	83993
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	onxx-20120331_lab.xml	EX-101.LAB	337764
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	onxx-20120331_pre.xml	EX-101.PRE	241229

Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080

Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000

ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)